Suguru Odajima

4PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 30, 2026
Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study.

|Jul 25, 2026
Outcome of advanced ovarian cancer patients who do not undergo cytoreductive surgery in the era of PARP inhibitors maintenance therapy: a propensity score-based analysis.

|Oct 24, 2023
Short- and long-term morbidity of total parietal peritonectomy for advanced ovarian cancer.

Suguru Odajima, Hiroshi Tanabe, Yuki Koike

|Jun 17, 2022
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data.

Suguru Odajima, Toshiyuki Seki, Sayako Kato

Pageof 1

Frequent Collaborators

3 joint publications

Aikou Okamoto

3 joint publications

Hiroshi Tanabe

2 joint publications

Kenichi Harano

2 joint publications

Toru Mukohara